Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rosenblatt

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Nature Chemical Biology|September 19, 2009
When two keys fit one lock, surprises followMichael Rosenblatt
Annals of the American Thoracic Society|March 20, 2013
How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, CaliforniaMichael Rosenblatt
The New England Journal of Medicine|April 6, 2017
Clinical Trials Series — Large PharmaMichael Rosenblatt
The New England Journal of Medicine|January 5, 2017
The Large Pharmaceutical Company PerspectiveMichael Rosenblatt
Science Translational Medicine|April 29, 2016
An incentive-based approach for improving data reproducibilityMichael Rosenblatt
Transactions of the American Clinical and Climatological Association|January 11, 2013
A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to boneMichael Rosenblatt
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 24, 2003
Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspectiveMichael Rosenblatt
The New England Journal of Medicine|January 31, 2014
Access to patient-level trial dataHal Barron, Michael Rosenblatt,
JAMA|April 24, 2015
Principles and challenges in access to experimental medicinesMichael Rosenblatt, Bruce Kuhlik
JAMA|September 23, 2015
FDA Expanded Access Programs for Experimental Medicines--ReplyMichael Rosenblatt, Bruce Kuhlik
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Nature Chemical Biology|September 19, 2009
When two keys fit one lock, surprises followMichael Rosenblatt
Annals of the American Thoracic Society|March 20, 2013
How academia and the pharmaceutical industry can work together: the president's lecture, annual meeting of the American Thoracic Society, San Francisco, CaliforniaMichael Rosenblatt
The New England Journal of Medicine|April 6, 2017
Clinical Trials Series — Large PharmaMichael Rosenblatt
The New England Journal of Medicine|January 5, 2017
The Large Pharmaceutical Company PerspectiveMichael Rosenblatt
Science Translational Medicine|April 29, 2016
An incentive-based approach for improving data reproducibilityMichael Rosenblatt
Transactions of the American Clinical and Climatological Association|January 11, 2013
A tale of mice and (wo)men: development of and insights from an "all human" animal model of breast cancer metastasis to boneMichael Rosenblatt
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|June 24, 2003
Is it ethical to conduct placebo-controlled clinical trials in the development of new agents for osteoporosis? An industry perspectiveMichael Rosenblatt
The New England Journal of Medicine|January 31, 2014
Access to patient-level trial dataHal Barron, Michael Rosenblatt,
JAMA|April 24, 2015
Principles and challenges in access to experimental medicinesMichael Rosenblatt, Bruce Kuhlik
JAMA|September 23, 2015
FDA Expanded Access Programs for Experimental Medicines--ReplyMichael Rosenblatt, Bruce Kuhlik
Pageof 5